CoChat

Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials

Yang, Bo, Tseng, Ping-Tao, Hu, Xiang, Zeng, Bing-Yan, Chang, Jane Pei-Chen, Liu, Yang, Chu, Wei-Jie, Zhang, Shuang-Shuang, Zhou, Zhi-Liang, Chu, Chih-Sheng, Chang, Cheng-Ho, Tu, Yu-Kang, Wu, Yi-Cheng, Stubbs, Brendon, Carvalho, Andre F., Lin, Pao-Yen, Matsuoka, Yutaka J., Suen, Mein-Woei, Su, Kuan-Pin · 2022 · Progress in Lipid Research
Cited by 21

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

The role of omega-3 polyunsaturated fatty acids (PUFAs) in primary and secondary prevention on major cardiovascular events (MCE) is inconclusive due to the potential heterogeneity in study designs of formulas, dosages, and ratios of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from the findings of previous randomized controlled trials (RCTs). Here we conducted a comprehensive narrative review of pre-clinical studies and updated a network meta-analysis (NMA) to determine the comparative efficacy against MCE with different EPA/DHA dosages and formulas. We found that pure EPA was ranked the best option in the secondary prevention (hazard ratio: 0.72, 95% confidence interval: 0.65 to 0.81) from the NMA of 39 RCTs with 88,359 participants. There was no evidence of omega-3 PUFAs' efficacy in primary prevention. The mechanisms of omega-3 PUFAs' cardiovascular protection might link to the effects of anti-inflammation and stabilization of endothelial function from PUFA's derivatives including eicosanoids and the special pre-resolving mediators (SPMs).

Overview

Integrity signals

Registry

Crossref · 10.1016/j.plipres.2022.101196

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 46

  1. Matsumoto, 2008, Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice, Atherosclerosis, 197, 524, 10.1016/j.atherosclerosis.2007.07.023 · DOI
  2. Radosinska, 2013, Dietary omega-3 fatty acids attenuate myocardial arrhythmogenic factors and propensity of the heart to lethal arrhythmias in a rodent model of human essential hypertension, J. Hypertens., 31, 1876, 10.1097/HJH.0b013e328362215d · DOI
  3. Imamura, 2018, Omega-3 therapy is associated with reduced gastrointestinal bleeding in patients with continuous-flow left ventricular assist device, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.118.005082 · DOI
  4. Zhuang, 2019, Dietary fats in relation to total and cause-specific mortality in a prospective cohort of 521 120 individuals with 16 years of follow-up, Circ. Res., 124, 757, 10.1161/CIRCRESAHA.118.314038 · DOI
  5. Adkins, 2010, Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids, J. Nutr. Biochem., 21, 781, 10.1016/j.jnutbio.2009.12.004 · DOI · Paper page
  6. Alexander, 2017, A Meta-analysis of randomized controlled trials and prospective cohort studies of Eicosapentaenoic and docosahexaenoic long-chain Omega-3 fatty acids and coronary heart disease risk, Mayo Clin. Proc., 92, 15, 10.1016/j.mayocp.2016.10.018 · DOI · Paper page
  7. Aung, 2018, Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 individuals, JAMA Cardiol., 3, 225, 10.1001/jamacardio.2017.5205 · DOI · Paper page
  8. 2022, Essays Biochem, 64, 397
  9. Rizos, 2021, Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis, Heart, 107, 150, 10.1136/heartjnl-2020-316780 · DOI · Paper page
  10. Abdelhamid, 2018, Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst. Rev., 11, CD012345
  11. Kris-Etherton, 2002, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Circulation, 106, 2747, 10.1161/01.CIR.0000038493.65177.94 · DOI · Paper page
  12. Hsieh, 2019, Effects of different pharmacologic smoking cessation treatments on body weight changes and success rates in patients with nicotine dependence: a network meta-analysis, Obes. Rev., 20, 895, 10.1111/obr.12835 · DOI
  13. Zeng, 2019, Prevention of postdental procedure bacteremia: a network meta-analysis, J. Dent. Res., 98, 1204, 10.1177/0022034519870466 · doi:10.1177/0022034519870466
  14. Chen, 2021, Efficacy of pharmacologic treatment in tinnitus patients without specific or treatable origin: a network meta-analysis of randomised controlled trials, EClinicalMedicine, 39, 10.1016/j.eclinm.2021.101080 · DOI
  15. Wang, 2021, Association of pharmacological prophylaxis with the risk of pediatric emergence delirium after sevoflurane anesthesia: an updated network meta-analysis, J. Clin. Anesth., 75, 10.1016/j.jclinane.2021.110488 · DOI
  16. Tseng, 2022, The dose- and duration-dependent association between melatonin treatment and overall cognition in Alzheimer’s dementia: a network meta-analysis of randomized placebo-controlled trials, Curr. Neuropharmacol., 20, 1816, 10.2174/1570159X20666220420122322 · DOI
  17. Tu, 2014, Use of generalized linear mixed models for network meta-analysis, Med. Decis. Mak., 34, 911, 10.1177/0272989X14545789 · DOI · Paper page
  18. White, 2015, Network meta-analysis, Stata J, 15, 951, 10.1177/1536867X1501500403 · DOI · Paper page
  19. Salanti, 2011, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial, J. Clin. Epidemiol., 64, 163, 10.1016/j.jclinepi.2010.03.016 · DOI · Paper page
  20. Averna, 2021, Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: a statement from a European atherosclerosis society task force, Atherosclerosis, 325, 99, 10.1016/j.atherosclerosis.2021.03.039 · DOI · Paper page
  21. Manson, 2012, The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease, Contemp Clin Trials, 33, 159, 10.1016/j.cct.2011.09.009 · DOI · Paper page
  22. Manson, 2020, Vitamin D, marine n-3 fatty acids, and primary prevention of cardiovascular disease current evidence, Circ. Res., 126, 112, 10.1161/CIRCRESAHA.119.314541 · DOI
  23. Heshmati, 2019, Omega-3 fatty acids supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials, Pharmacol. Res., 149, 10.1016/j.phrs.2019.104462 · DOI · Paper page
  24. Johansson, 2015, The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells, Autophagy, 11, 1636, 10.1080/15548627.2015.1061170 · DOI
  25. Asano, 1999, Eicosapentaenoic acid inhibits vasopressin-activated Ca2+ influx and cell proliferation in rat aortic smooth muscle cell lines, Eur. J. Pharmacol., 379, 199, 10.1016/S0014-2999(99)00476-8 · DOI
  26. Mason, 2015, Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism, Biochim. Biophys. Acta, 1848, 502, 10.1016/j.bbamem.2014.10.016 · DOI · Paper page
  27. Allam-Ndoul, 2017, Effect of different concentrations of omega-3 fatty acids on stimulated THP-1 macrophages, Genes Nutr., 12, 7, 10.1186/s12263-017-0554-6 · DOI
  28. Brown, 2020, Mechanisms underlying N3-PUFA regulation of white adipose tissue endocrine function, Curr. Opin. Pharmacol., 52, 40, 10.1016/j.coph.2020.04.009 · DOI
  29. Oh, 2010, GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects, Cell, 142, 687, 10.1016/j.cell.2010.07.041 · DOI · Paper page
  30. Custers, 2022, Dietary lipids from body to brain, Prog. Lipid Res., 85, 10.1016/j.plipres.2021.101144 · DOI
  31. Michell, 2020, Mike Wakelam: an appreciation, Essays Biochem., 64, 397, 10.1042/EBC20200042 · doi:10.1042/ebc20200042
  32. Crupi, 2022, Role of EPA in inflammation: mechanisms, effects, and clinical relevance, Biomolecules, 12, 10.3390/biom12020242 · DOI
  33. Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat Rev Immunol, 8, 349, 10.1038/nri2294 · DOI · Paper page
  34. Watanabe, 2020, Prevention of cardiovascular events with omega-3 polyunsaturated fatty acids and the mechanism involved, J. Atheroscler. Thromb., 27, 183, 10.5551/jat.50658 · DOI
  35. Tang, 2019, The status of omega-3 PUFAs influence chronic unpredicted mild stress-induced metabolic side effects in rats through INSIG/SREBP pathway, Food Funct., 10, 4649, 10.1039/C9FO00076C · DOI
  36. Gnoni, 2016, Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver, J. Physiol. Biochem., 72, 485, 10.1007/s13105-016-0495-3 · DOI
  37. Shemesh, 2019, Hypertriglyceridemia-related pancreatitis in patients with type 2 diabetes: links and risks, Diabetes Metab Syndr Obes, 12, 2041, 10.2147/DMSO.S188856 · DOI
  38. Grevengoed, 2021, An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides, J. Clin. Invest., 131, 10.1172/JCI143861 · DOI
  39. Coker, 2022, Linking anaerobic gut bacteria and cardiovascular disease, Nat. Microbiol., 7, 14, 10.1038/s41564-021-01009-4 · DOI
  40. Chang, 2014, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, Proc. Natl. Acad. Sci. U. S. A., 111, 2247, 10.1073/pnas.1322269111 · DOI · Paper page
  41. Rousseau, 2021, Microbiota, a new playground for the omega-3 polyunsaturated fatty acids in cardiovascular diseases, Mar Drugs, 19, 10.3390/md19020054 · DOI
  42. Wawrzyniak, 2021, Nutritional lipids and mucosal inflammation, Mol. Nutr. Food Res., 65
  43. Zhang, 2019, Potential of omega-3 polyunsaturated fatty acids in managing chemotherapy- or radiotherapy-related intestinal microbial dysbiosis, Adv. Nutr., 10, 133, 10.1093/advances/nmy076 · DOI
  44. Riviere, 2016, Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut, Front. Microbiol., 7, 979, 10.3389/fmicb.2016.00979 · DOI · Paper page
  45. Bryhn, 2006, The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters, Prostaglandins Leukot Essent Fatty Acids, 75, 19, 10.1016/j.plefa.2006.04.003 · DOI
  46. Maki, 2018, Omega-6 polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps, Adv. Nutr., 9, 688, 10.1093/advances/nmy038 · DOI

Cited by

See all 21

Metadata

Authors
Yang, B., Tseng, P.-T., Hu, X., Zeng, B.-Y., Chang, J. P.-C., Liu, Y., Chu, W.-J., Zhang, S.-S., Zhou, Z.-L., Chu, C.-S., Chang, C.-H., Tu, Y.-K., Wu, Y.-C., Stubbs, B., Carvalho, A. F., Lin, P.-Y., Matsuoka, Y. J., Suen, M.-W., & Su, K.-P.
Venue
Progress in Lipid Research
Publisher
Elsevier BV
Published
2022-11
Volume
88
Pages
101196
ISSN
0163-7827
Cited by
21
References
35
Language
en
Update notices
erratum (2023-01-01)
Funders
  • Maudsley Charity
  • Chinese Nutrition Society
  • Collaboration for Leadership in Applied Health Research and Care - Greater Manchester
  • National Health Research Institutes
  • Tainan Municipal An-Nan Hospital
  • SENSHIN Medical Research Foundation
  • China Medical University, Taiwan (CMRC-CMA-2)
  • China Medical University Hospital (ICA-CL-2017-03-001)
  • National Cancer Center (30-A-17)
  • Wenzhou Medical University (89217015)
  • Japan Society for the Promotion of Science (17H04253)
  • Ministry of Education (DMR-109-102, DMR-HHC-110-10, DMR-HHC-109-11, DMR-103-084, DMR-107-204, DMR-108-216, CMU 110-AWARD-02, DMR-HHC-109-12, DMR-110-124, CMU108-SR-106, CRS-108-048, DMR-106-225, DMR-109-244, DMR-102-076)
  • NIHR Collaboration for Leadership in Applied Health Research and Care South London
  • Ministry of Health, Labour and Welfare (H30-Cancer Policy-General-005)
  • King's College London
  • Ministry of Science and Technology, Taiwan (109\u201340, 111\u201348, ANHRF 109\u201331, 110\u201345, 111\u201327, 111\u201347, 110\u201344, 111\u201328, 110\u201326, 111\u201352, 110\u20132314-B-039-029-MY3, 110\u20132320-B-039-047-MY3, 111\u20132321-B-006-008, 110\u20132813-C-039-327-B, 110\u20132321-B-006-004, 109\u20132320-B-038-057-MY3, 110\u20132811-B-039-507, 111\u20132314-B-039-041-MY3, 110\u20132320-B-039-048-MY2, 109\u20132320-B-039-066)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1016/j.plipres.2022.101196
The paper
Yang, B., Tseng, P.-T., Hu, X., Zeng, B.-Y., Chang, J. P.-C., Liu, Y., Chu, W.-J., Zhang, S.-S., Zhou, Z.-L., Chu, C.-S., Chang, C.-H., Tu, Y.-K., Wu, Y.-C., Stubbs, B., Carvalho, A. F., Lin, P.-Y., Matsuoka, Y. J., Suen, M.-W., & Su, K.-P. (2022). Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials. Progress in Lipid Research. https://doi.org/10.1016/j.plipres.2022.101196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.